169 related articles for article (PubMed ID: 20074451)
1. Decrease in phosphorylation of ERK following decreased expression of NK cell-activating receptors in human NK cell line exposed to asbestos.
Nishimura Y; Maeda M; Kumagai N; Hayashi H; Miura Y; Otsuki T
Int J Immunopathol Pharmacol; 2009; 22(4):879-88. PubMed ID: 20074451
[TBL] [Abstract][Full Text] [Related]
2. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers.
Nishimura Y; Miura Y; Maeda M; Kumagai N; Murakami S; Hayashi H; Fukuoka K; Nakano T; Otsuki T
Int J Immunopathol Pharmacol; 2009; 22(3):579-90. PubMed ID: 19822075
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effect of asbestos on cytotoxicity of human NK cells.
Nishimura Y; Kumagai N; Maeda M; Hayashi H; Fukuoka K; Nakano T; Miura Y; Hiratsuka J; Otsuki T
Int J Immunopathol Pharmacol; 2011; 24(1 Suppl):5S-10S. PubMed ID: 21329559
[TBL] [Abstract][Full Text] [Related]
4. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways.
Chuang SS; Kumaresan PR; Mathew PA
J Immunol; 2001 Dec; 167(11):6210-6. PubMed ID: 11714782
[TBL] [Abstract][Full Text] [Related]
5. Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.
Jiang K; Zhong B; Gilvary DL; Corliss BC; Vivier E; Hong-Geller E; Wei S; Djeu JY
J Immunol; 2002 Apr; 168(7):3155-64. PubMed ID: 11907067
[TBL] [Abstract][Full Text] [Related]
6. NK cell function triggered by multiple activating receptors is negatively regulated by glycogen synthase kinase-3β.
Kwon HJ; Kwon SJ; Lee H; Park HR; Choi GE; Kang SW; Kwon SW; Kim N; Lee SY; Ryu S; Kim SC; Kim HS
Cell Signal; 2015 Sep; 27(9):1731-41. PubMed ID: 26022178
[TBL] [Abstract][Full Text] [Related]
7. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
Zhang C; Zhang J; Niu J; Zhang J; Tian Z
Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.
Sun C; Fu B; Gao Y; Liao X; Sun R; Tian Z; Wei H
PLoS Pathog; 2012; 8(3):e1002594. PubMed ID: 22438812
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of activating NK-cell receptors 2B4 and NKG2D to membrane microdomains in mammalian cells is dependent on their transmembrane regions.
Gütgemann SA; Sandusky MM; Wingert S; Claus M; Watzl C
Eur J Immunol; 2015 Apr; 45(4):1258-69. PubMed ID: 25545687
[TBL] [Abstract][Full Text] [Related]
11. IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway.
Song H; Park H; Kim J; Park G; Kim YS; Kim SM; Kim D; Seo SK; Lee HK; Cho D; Hur D
Immunol Lett; 2011 May; 136(2):187-93. PubMed ID: 21277902
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways.
Lu CC; Chen JK
J Cell Physiol; 2010 May; 223(2):343-51. PubMed ID: 20082299
[TBL] [Abstract][Full Text] [Related]
13. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
[TBL] [Abstract][Full Text] [Related]
14. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.
Garcia-Iglesias T; Del Toro-Arreola A; Albarran-Somoza B; Del Toro-Arreola S; Sanchez-Hernandez PE; Ramirez-Dueñas MG; Balderas-Peña LM; Bravo-Cuellar A; Ortiz-Lazareno PC; Daneri-Navarro A
BMC Cancer; 2009 Jun; 9():186. PubMed ID: 19531227
[TBL] [Abstract][Full Text] [Related]
15. Role for glycogen synthase kinase-3 in NK cell cytotoxicity and X-linked lymphoproliferative disease.
Aoukaty A; Tan R
J Immunol; 2005 Apr; 174(8):4551-8. PubMed ID: 15814676
[TBL] [Abstract][Full Text] [Related]
16. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
[TBL] [Abstract][Full Text] [Related]
17. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
18. Functional role of human NK cell receptor 2B4 (CD244) isoforms.
Mathew SO; Rao KK; Kim JR; Bambard ND; Mathew PA
Eur J Immunol; 2009 Jun; 39(6):1632-41. PubMed ID: 19499526
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C is involved in 2B4 (CD244)-mediated cytotoxicity and AP-1 activation in natural killer cells.
Chuang SS; Lee JK; Mathew PA
Immunology; 2003 Jul; 109(3):432-9. PubMed ID: 12807490
[TBL] [Abstract][Full Text] [Related]
20. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.
Aoukaty A; Tan R
J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
